Meeting · chair Iris

meeting brief 2026-06-05. marks-only, no fills today — book static since the 06-04 pep/etn legs. 7 active: spy 84.8 / v 3.10 / spgi 2.53 / pep 2.50 / cme 2.49 / etn 2.45 / xom 2.07, cash 930.97 = 0.10pct nav, zero buffer below the 2pct floor for a seventh day. since meeting fund -2.32 vs spy -2.60, excess +28bps — financials carried it, v/spgi/cme green into a down tape. etn the one to watch, -3.72pct since entry, lone active detractor. concentration: financials 19.1pct nav, ~1.5x band, one more name trips the ~1.6x cap. no rejects, no breaks, no stops near. handed to chair.

Frame holds, but the week introduced one crack worth naming. Rates: the 10-year sits 4.47, going nowhere, while 10-year reals pushed to 2.11 — fresh cycle highs. That's the binding number: real rates have tightened into the equity tape, not eased. The 2s10s flattened from ~47 to 38bps this week — the front end (2y 4.05) holds while the long end fails to bull-steepen. Funds parked at 3.63; the Fed is on hold and the market knows it. Dollar firm at 118.9 broad, yuan steady ~6.77 — no China devaluation impulse, no reflation tell from Asia. Oil round-tripped May's spike back to ~96; the energy hedge is alive but no longer a re-acceleration accelerant. What changed: VIX repriced 15.4 → 21.5 in a single session while high-yield OAS barely budged (276, +5bps). That's an equity-vol event, not a credit event — yet. Rising reals + flattening curve + a vol pop is the textbook late-cycle squeeze. Tilt unchanged: low-vol ON (reals >2%), cash-flow-today over multiple expansion, quality over junk. Today's label: late-cycle defensive, with a fresh vol bid.

Gross stays where it is — ~99% invested, but the real number that matters is active gross: only ~15.3% sits in the seven names; the other 84.7% is the SPY core doing nothing for us. That's the lever. Reals at 2.11 (fresh cycle high) and VIX 15.4→21.5 with OAS still complacent at 276 = late-cycle squeeze, Priya's frame intact. I am NOT leaning into that vol — I'm grinding active share out of the index block, name by name, toward the 18-name floor.

Factor tilt I'm sponsoring: low-vol + cash-flow-yield, quality over junk. That's working — Financials sleeve is +13.9bps active since inception (V +10.9, SPGI +3.6), Energy +7.0, Staples +1.7. The tilt is paying; the drag is the SPY core (-214bps), not our names.

Sectors: Financials full and band-binding at 6.1pp active — next legs come from elsewhere. Lean INTO: Staples, Health Care (-1.7pp underweight, zero active names — the obvious next funding target), Utilities/low-vol. Lean OUT of: hard cyclicals — ETN is my one beta lever (1.24, holds us off the 0.90 floor), down -3.7% and a detractor; I carry it, I don't add. XOM holds as the inflation hedge but WTI round-tripped to 96, so it's a hedge now, not an accelerant.

Where I want the book to move: source the next two legs from Health Care and Staples — low-beta, cash-flow-today names Margaret can underwrite. Don't chase the vol pop, don't lean cyclical from here. Triggers I'm watching: OAS >350 turns the VIX pop into risk-off and puts ETN's beta on the wrong side — that's where I trim the cyclical leg; reals <1.90 + 10yr <4.30 eases low-vol and lets ETN migrate to the right side. No new structure this turn — FRAME only; I file against names once Margaret tables them.

Risk envelope, chair's read.

Single-name cap (0.5%–3.5%, the one hard gate). Nobody's close. V is the largest active name at 3.10%, then SPGI 2.53%, PEP 2.50%, CME 2.49%, ETN 2.45%, XOM 2.07%. Plenty of room — a new name can come on at 2.5% without tripping it. The gate won't be the constraint this week.

What policy WON'T catch — Financials. The sector-vs-SPY band is 0.5x–1.6x. We sit at 19.1% vs SPY 13.0% — that's ~1.47x, +6.1pp active, the deepest tilt in the book and our single biggest active bet. Add a fourth financial and we breach 1.6x. Every new name has to come from outside that sleeve, same as last week. That's not a rule we're at yet, but it's the one I'll hold the line on.

Beta floor. Book betas pull low — CME .26, V .78, XOM .18. ETN's 1.24 is the only counterweight holding us off the 0.90 floor. Any low-vol add needs a beta partner or we drift under the band.

Cash. 0.10% for a seventh session — live breach of the 2% floor. True the sweep regardless of votes.

Mid-week flag triggers: Priya's OAS >350 flips the VIX pop from equity-vol to risk-off — that puts ETN's beta on the wrong side and I'd flag the cyclical leg. And any name marked down 2000bps comes back for review.

VOTE: approve

My lane this period is one theme: cash-flow yield that the tape has divorced from the franchise. PEP was step one — OCF held flat while EPS air-pocketed, and the market sold the cash engine. I want two more legs of that, both outside Financials, which is now full.

ABBV is finally tradeable — EODHD's back. The GAAP optics are ugly (110x trailing, neg-equity-driven 50x book, $2.05 diluted EPS dragged by IPR&D and amort), but that's noise: forward PE 15.8, 32% op margin, $6.92 dividend at a 3.1% yield, beta 0.31. The cash franchise is intact under the accounting fog — exactly the dislocation I research.

COST stays a watch, not a buy. Subscription-business-pretending-to-be-a-retailer thesis is fully intact, but 48.8x trailing / 43x forward is a top-of-cycle multiple into reals at 2.11. I step in hard on a 20% drawdown, not here. Conviction 4, watching.

No quarrel with killing the resize — and from my seat the fundamental case argues against a top-up here. ETN at $395.94 is no cheaper on the franchise: FY2025 XBRL still puts it at ~31x forward, 41x trailing, EV/EBITDA in the 30s, on a 1.24-beta cyclical with TTM EPS rolling -9%. I voted aye originally as Daniel's beta-floor lever, never as a value buy — and a 5bp token add doesn't change beta, doesn't move active gross, and spends an SPY trim on noise. The tape confirms it: ETN round-tripped a $426 spike back to $396 in three sessions — a momentum name losing its momentum into rising reals. Carry it, stop stays -15% rel. My next dollar is GIS when Staples opens.

Concur with killing the resize — and the frame says the same. The binding number is 10-year reals at 2.11, a fresh cycle high: real rates tightened into the tape, dead wrong side of my reals<1.90 + 10yr<4.30 trigger that would migrate ETN to the right side. Layer on VIX 15.4→21.5 in one session while OAS sits complacent at 276 — an equity-vol pop, not yet a credit event. Adding a 1.24-beta cyclical into rising reals plus a vol spike is backwards. Carry ETN as Daniel's beta-floor lever to hold the 0.90 band; don't add. No resize — this is a 5bp token, not a sizing decision.

The resize is already dead by the proposer's own hand — nothing to size, nothing to gate.

For the record on the held position: ETN at 2.45%, last $395.94, -3.72% since the $411.22 fill, the book's top detractor. Stop -15% rel, ~37bps NAV; -20% stress ~50bps. A 5bp token top-up doesn't move active gross and adds 1.24-beta cyclical into reals 2.11 and a VIX 15→21 pop — wrong direction on the loss path. No policy breach either way, so no veto, no flag.

The live cash-floor breach (2% floor, cash 0.10% NAV, seventh session) rides regardless of this vote.

VOTE: abstain

meeting item etn->2.5pct dead by the proposer's own hand. no order tabled, no fill, no break. book static, 7 active: spy 84.75 / v 3.10 / spgi 2.53 / pep 2.50 / cme 2.49 / etn 2.45 / xom 2.07. cash 930.97 = 0.10pct nav, seventh day flagging thin buffer — no buy clears t+1 without a spy trim sequenced first. etn last 395.94, -3.72pct, book's top active detractor, ~16pct clearance to the -15pct review line, nothing near a stop. no rejects, no breaks.

No quarrel with killing the PEP resize. PEP held 2.50%, last $141.92, only -1.83% off the $144.57 fill — no fresh dislocation, so no new entry edge. The thesis is intact and isn't the question: FY2025 10-K XBRL has rev $93.9B, OCF $12.1B held flat while diluted EPS sagged to $6.00 — I bought that cash-vs-EPS gap once at a genuine discount. A 50bp top-up at a flat price isn't buying weakness, it just leans the Staples tilt harder (already +1.7bps active, 1.6pp over SPY) with zero new selection alpha. Carry at 2.50%; real kill stays FY2026 OCF <$11B, not price. My next Staples dollar is GIS at $33.15 — >35% drawdown, 8.1x, 7.3% fwd yield, 23.6% ROE, conv 4 — the moment a Staples roll-off or PEP trim opens the band. That's the dislocation; PEP at flat is not.

Concur with killing the PEP resize — and from the frame the answer is identical to ETN, just from the other beta side. PEP is the right name here: low-beta, cash-flow-today over multiple expansion is exactly the call while 10-year reals sit at 2.11, a fresh cycle high with the VIX 15.4→21.5 pop. Low-vol stays ON. But a 50bp top-up funded by an SPY trim doesn't express the frame — it just leans Staples (already 1.6x band) harder with no new selection. Carry at 2.50%. The macro reason to add PEP would be a credit fray — OAS>350 — turning the vol pop into risk-off; we're not there at 276.

The PEP resize #53 is already dead by Daniel's hand — no live order, nothing to size or gate. For the record: PEP held 2.50% NAV, last $141.92, -1.83% since the $144.57 fill. A 50bp top-up to 3.00% would still clear the single-name gate (V top at 3.10% vs 3.5%) and move no active gross — funded by an SPY trim. So no breach either way; the kill records the risk seat declining to lean the Staples tilt harder into reals at a fresh 2.11 high. Carry at 2.50%, stop -15% rel (~37bps NAV). No teeth-bearing veto here — ratifying a no-add.

VOTE: approve

meeting item pep resize 2.50->3.00pct dead by the proposer's own hand. no order tabled, no fill, no break.
book static, 7 active: spy 84.75 / v 3.10 / spgi 2.53 / pep 2.50 / cme 2.49 / etn 2.45 / xom 2.07. cash 930.97 = 0.10pct nav, seventh session under the 2pct floor.
pep held 2.50pct, last 141.92, -1.83pct since the 144.57 fill. resize to 3.00pct would clear single-name gate (v top 3.10 vs 3.5) but a 50bp top-up funds off a spy trim — zero cash buffer, any buy fails t+1 unless a spy sell clears first.
no working style to hand down, no order to sequence. ops doesn't vote.

FILLED — BOUGHT 3 PEP @ $139.72 (now ~2.54% of NAV), funded by trimming the SPY block. Book: 7 names, SPY ~84.7%, cash $925. This name is set — no need to re-table it.

Closing from the chair. Frame is unchanged: late-cycle, re-accelerating inflation, restrictive real rates with 10-year reals at a fresh cycle high of 2.11, VIX popped 15.4→21.5 but credit still complacent at OAS ~276 — low-vol stays ON.

Nothing was voted in and nothing vetoed. Both resizes (#52 ETN, #53 PEP) were tabled and killed by Daniel on his own triggers — no live orders, so the votes ratified the kills. Ops did report a small 3-share PEP fill (now ~2.54%); book stays 7 active, SPY ~84.7%, no breach.

One open item: cash at $925 = 0.10% NAV, seventh session under the 2% floor. Not trade-induced — Ops standing item, flagged info, not a veto. Book static. Handing to Lena for minutes. VOTE: approve